119 related articles for article (PubMed ID: 3866254)
1. Vasoactive intestinal polypeptide acts synergistically with norepinephrine to depress spontaneous discharge rate in cerebral cortical neurons.
Ferron A; Siggins GR; Bloom FE
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8810-2. PubMed ID: 3866254
[TBL] [Abstract][Full Text] [Related]
2. Norepinephrine and histamine potentiate the increases in cyclic adenosine 3':5'-monophosphate elicited by vasoactive intestinal polypeptide in mouse cerebral cortical slices: mediation by alpha 1-adrenergic and H1-histaminergic receptors.
Magistretti PJ; Schorderet M
J Neurosci; 1985 Feb; 5(2):362-8. PubMed ID: 2983040
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandins and the synergism between VIP and noradrenaline in the cerebral cortex.
Schaad NC; Schorderet M; Magistretti PJ
Nature; 1987 Aug 13-19; 328(6131):637-40. PubMed ID: 3039374
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated cyclic AMP synthesis in rat cerebral cortical slices: interaction with noradrenaline, adrenaline, and forskolin.
Nowak JZ; Kuba K
J Mol Neurosci; 2002; 18(1-2):47-52. PubMed ID: 11931349
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural evidence for combined action of noradrenaline and vasoactive intestinal polypeptide upon neurons, astrocytes, and blood vessels of the rat cerebral cortex.
Paspalas CD; Papadopoulos GC
Brain Res Bull; 1998; 45(3):247-59. PubMed ID: 9510417
[TBL] [Abstract][Full Text] [Related]
6. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
7. Effects of vasoactive intestinal polypeptide on the response properties of cells in area 17 of the cat visual cortex.
Murphy PC; Grieve KL; Sillito AM
J Neurophysiol; 1993 May; 69(5):1465-74. PubMed ID: 8389825
[TBL] [Abstract][Full Text] [Related]
8. VIP and noradrenaline act synergistically to increase cyclic AMP in cerebral cortex.
Magistretti PJ; Schorderet M
Nature; 1984 Mar 15-21; 308(5956):280-2. PubMed ID: 6322012
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of cyclic AMP elicited by vasoactive intestinal peptide is potentiated by noradrenaline, histamine, adenosine, baclofen, phorbol esters, and ouabain in mouse cerebral cortical slices: studies on the role of arachidonic acid metabolites and protein kinase C.
Schaad NC; Schorderet M; Magistretti PJ
J Neurochem; 1989 Dec; 53(6):1941-51. PubMed ID: 2553869
[TBL] [Abstract][Full Text] [Related]
10. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological actions of VIP in rat somatosensory cortex.
Sessler FM; Grady SM; Waterhouse BD; Moises HC
Peptides; 1991; 12(4):715-21. PubMed ID: 1788134
[TBL] [Abstract][Full Text] [Related]
12. Cortical vasodilatation produced by vasoactive intestinal polypeptide (VIP) and by physiological stimuli in the cat.
Yaksh TL; Wang JY; Go VL
J Cereb Blood Flow Metab; 1987 Jun; 7(3):315-26. PubMed ID: 3108270
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells.
Bjurholm A; Kreicbergs A; Schultzberg M; Lerner UH
J Bone Miner Res; 1992 Sep; 7(9):1011-9. PubMed ID: 1384276
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism.
Magistretti PJ; Morrison JH; Shoemaker WJ; Sapin V; Bloom FE
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6535-9. PubMed ID: 6118864
[TBL] [Abstract][Full Text] [Related]
15. Neurotransmitters acting via different G proteins inhibit N-type calcium current by an identical mechanism in rat sympathetic neurons.
Ehrlich I; Elmslie KS
J Neurophysiol; 1995 Dec; 74(6):2251-7. PubMed ID: 8747188
[TBL] [Abstract][Full Text] [Related]
16. Actions of vasoactive intestinal polypeptide (VIP) on neocortical neurons of the rat in vitro.
Pawelzik H; Dodt HU; Zieglgänsberger W
Neurosci Lett; 1992 Dec; 147(2):167-70. PubMed ID: 1491801
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of vasodilation induced by vasoactive intestinal polypeptide in rabbit mesenteric artery.
Itoh T; Sasaguri T; Makita Y; Kanmura Y; Kuriyama H
Am J Physiol; 1985 Aug; 249(2 Pt 2):H231-40. PubMed ID: 2992292
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide elevates pinealocyte intracellular calcium concentrations by enhancing influx: evidence for involvement of a cyclic GMP-dependent mechanism.
Schaad NC; Vanecek J; Rodriguez IR; Klein DC; Holtzclaw L; Russell JT
Mol Pharmacol; 1995 May; 47(5):923-33. PubMed ID: 7538196
[TBL] [Abstract][Full Text] [Related]
19. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II and norepinephrine antagonize the secretory effect of VIP in rat ileum and colon.
Bhaskar Rao M; O'Dorisio TM; Cataland S; George JM; Gaginella TS
Peptides; 1984; 5(2):291-4. PubMed ID: 6473156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
